SUs are as effective as GLP-1RAs in HbA 1C reduction and have fewer GI effects, but they can lead to weight gain and also a higher risk of hypoglycaemia, which this patient needs to avoid
In terms of application, segmentation covers type 2 diabetes mellitus, obesity, and others, with type 2 diabetes mellitus holding the largest share at 62.3%
AAV vectors are generally safe at therapeutic doses eight AAV-based gene therapies have been FDA-approved as of 2024 but at high doses, above roughly 10^14 viral genomes per kilogram, the literature documents immune reactions, liver toxicity, and in rare cases, genotoxicity
As always, the efficacy and safety of these treatments may vary and should be discussed with a qualified healthcare provider.
Taking a dose 24 hours ahead of schedule is a common request for individuals managing busy lifestyles